Thursday, October 28, 2021  | 21 Rabiulawal, 1443
Samaa TV
Facebook Twitter Youtube
HOME > Health

WHO gives emergency use authorisation to Moderna COVID-19 vaccine

Moderna is fifth vaccine to be approved by WHO

SAMAA | - Posted: May 1, 2021 | Last Updated: 6 months ago
SAMAA |
Posted: May 1, 2021 | Last Updated: 6 months ago

Photo: AFP

Listen to the story
The World Health Organization on Friday said it had listed the anti-Covid-19 Moderna vaccine for emergency use. The listing procedure helps countries unable to assess a vaccine's effectiveness themselves have access as quickly as possible and allow the Covax vaccine sharing scheme and other partners to distribute it to poorer countries. The US vaccine is the fifth jab to earn WHO's emergency listing. The US Food and Drug Administration issued an emergency use authorization for the Moderna vaccine on December 18, 2020 and a marketing authorisation valid throughout the European Union was granted by the European Medicines Agency on January 6, 2021. WHO said in a statement that its Strategic Advisory Group of Experts on Immunization (SAGE) had found the Moderna vaccine to have an efficacy of 94.1%. Moderna's vaccine is stored at freezer temperatures of -20°C. The other vaccines listed for emergency use by WHO are Pfizer BioNTech; AstraZeneca; Serum Institute of India; and Janssen. Moderna on Thursday said it expected to produce up to three billion doses of its vaccine in 2022 through new funding commitments to boost supply at manufacturing sites in Europe and the US.
FaceBook WhatsApp

The World Health Organization on Friday said it had listed the anti-Covid-19 Moderna vaccine for emergency use.

The listing procedure helps countries unable to assess a vaccine’s effectiveness themselves have access as quickly as possible and allow the Covax vaccine sharing scheme and other partners to distribute it to poorer countries.

The US vaccine is the fifth jab to earn WHO’s emergency listing.

The US Food and Drug Administration issued an emergency use authorization for the Moderna vaccine on December 18, 2020 and a marketing authorisation valid throughout the European Union was granted by the European Medicines Agency on January 6, 2021.

WHO said in a statement that its Strategic Advisory Group of Experts on Immunization (SAGE) had found the Moderna vaccine to have an efficacy of 94.1%.

Moderna’s vaccine is stored at freezer temperatures of -20°C.

The other vaccines listed for emergency use by WHO are Pfizer BioNTech; AstraZeneca; Serum Institute of India; and Janssen.

Moderna on Thursday said it expected to produce up to three billion doses of its vaccine in 2022 through new funding commitments to boost supply at manufacturing sites in Europe and the US.

 
HOME  
 
 
RELATED STORIES

Tell us what you think:

Your email address will not be published.

FaceBook WhatsApp
 
 
 
Moderna covid-19 vaccine, moderna coronavirus vaccine, world health organisation, WHO emergency use authorisation, covid vaccine side effects moderna, moderna vs pfizer vaccine, side effects of covid vaccine, side effects of covid vaccine second dose, cdc covid vaccine, moderna vaccine side effects first dose, how long will it take to build immunity after getting the covid-19 vaccine? moderna vaccine side effects second dose
 
 
 
 
 
 
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp